Drug patent row: HC seeks Glenmark's response by May 22

Last Updated: Friday, April 12, 2013, 15:16

A bench of Justices S Ravindra Bhat and S K Mishra issued a notice to Glenmark and sought its reply by May 22 on the US firm's plea challenging the single judge order.

Glenmark initiates studies to develop new molecule 'GBR 830'

Last Updated: Monday, February 4, 2013, 17:34

Glenmark Pharmaceuticals Monday said it has initiated studies for the development of a new molecule 'GBR 830', which could possibly be used to treat diseases like Arthritis (RA) and bowel disease.

Glenmark US partner Salix gets USFDA nod for Crofelemer tablet

Last Updated: Wednesday, January 2, 2013, 14:41

Drug firm Glenmark Pharmaceuticals on Wednesday said US health regulator has granted marketing approval to its US partner Salix Pharmaceuticals for Crofelemer tablets used for treating diarrhoea in HIV patients.

Glenmark inks drug development pact with Forest Laboratories

Last Updated: Monday, December 24, 2012, 14:32

Glenmark Pharmaceuticals Monday said it has inked an agreement with US-based Forest Laboratories Inc to develop molecules to treat chronic inflammatory conditions.

Glenmark Q2 net up nearly three fold at Rs 156.75 cr

Last Updated: Tuesday, October 30, 2012, 19:38

The company had posted a net profit of Rs 56.58 crore for the quarter ended September 30, 2011, Glenmark Pharmaceuticals said in a statement.

Glenmark gets tentative nod from USFDA for migraine tablets

Last Updated: Thursday, September 20, 2012, 12:57

Glenmark Pharmaceuticals on Thursday said it has received tentative approval from the US health regulator for its generic Rizatriptan Benzoate tablets used for treating migraine attacks.

Glenmark enters phase II trial for new drug molecule

Last Updated: Thursday, September 13, 2012, 15:34

Drug maker Glenmark Pharmaceuticals on Thursday said it has entered the phase II clinical trials for its new drug molecule aimed at treating ulcerative colitis.

Glenmark gets favourable interim award against Napo

Last Updated: Thursday, August 23, 2012, 15:53

Glenmark Pharmaceuticals on Thursday said it has received a favourable interim award in a dispute against Napo Pharmaceuticals Inc regarding commercialisation of anti-diarrheal drug, Crofelemer, from International Centre for Dispute Resolution (ICDR).

Glenmark Q1 net at Rs 78 cr

Last Updated: Thursday, August 2, 2012, 23:24

Drug firm Glenmark Pharmaceuticals today posted a net profit of Rs 78.27 crore for the first quarter ended June 30, 2012.

Glenmark gets tentative nod from USFDA for migraine tablets

Last Updated: Wednesday, May 16, 2012, 14:49

Glenmark Pharmaceuticals Wednesday said it has received tentative approval from the US health regulator for generic Zolmitriptan tablets used for treating migraines.

Glenmark Q4 net up 33% at Rs 150 cr

Last Updated: Tuesday, May 8, 2012, 20:29

Glenmark Pharmaceuticals Tuesday said its consolidated net profit rose by 32.54 percent to Rs 150.35 crore for the fourth quarter ended March 31, 2012, on the back of robust sales in the domestic and US market.

Glenmark gets final USFDA nod for oral contraceptive pills

Last Updated: Tuesday, April 3, 2012, 14:03

Glenmark Pharmaceuticals on Tuesday said it has received final approval by the US health regulator to market its oral contraceptive Desogestrel and Ethinyl Estradiol tablets in the American market.